Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jan;115(1):112-8.
doi: 10.1309/6L34-V3AR-DW39-DH30.

Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration

Affiliations

Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration

F H Wians Jr et al. Am J Clin Pathol. 2001 Jan.

Abstract

We compared the ability of soluble serum transferrin receptor (TfR) concentration, quantified using the R&D Systems (Minneapolis, MN) enzyme-linked immunosorbent TfR assay, with other, more traditional indicators of iron status (total iron binding capacity [TIBC], mean corpuscular volume [MCV], percent transferrin saturation [%TS], RBC distribution width [RDW], and serum iron concentration [SIC]) for discriminating between patients with iron deficiency anemia (IDA) or anemia of chronic disease (ACD). The TfR concentration was determined in 72 serum samples selected from men and nonpregnant women classified biochemically on the basis of ferritin concentration as having IDA (n = 41) or ACD (n = 31). By using receiver operating characteristic curve analysis, the diagnostic accuracy of the various indicators of iron status that we evaluated for discriminating between IDA and ACD decreased in the following order: TIBC > TfR > MCV > (%TS = RDW) > SIC. There was no significant difference between the diagnostic accuracy of TIBC and TfR. Thus, the routine measurement of TfR offers no advantage over TIBC for discriminating between people with biochemically defined IDA or ACD.

PubMed Disclaimer

Comment in

  • Serum transferrin receptor.
    Lam QT, Schneider HG. Lam QT, et al. Am J Clin Pathol. 2001 Sep;116(3):446-7; author reply 447-9. Am J Clin Pathol. 2001. PMID: 11554175 No abstract available.
  • Serum transferrin receptor.
    Juncà J, Oriol A. Juncà J, et al. Am J Clin Pathol. 2001 Sep;116(3):446; author reply 447-9. Am J Clin Pathol. 2001. PMID: 11554176 No abstract available.

Similar articles

Cited by